c-LEcta is now in the process of being fully integrated under the Kerry brand, as a key element of Kerry’s growing biotechnology offering.
While the look and feel of our products such as Denarase and CellTrypase will be refreshed to reflect Kerry's global identity, the core elements you rely on will remain unchanged. You can expect the same high-quality formulations, manufacturing processes, and standards, as well as uninterrupted order, invoicing, and delivery processes. Your trusted contacts and our dedication to reliable service will remain the same.
Our transition to the Kerry brand will roll out gradually from early Q2 through early Q4, 2026. We will keep you updated every step of the way, ensuring you have all the information you need.
By uniting c-LEcta and Kerry, we're creating a stronger, more unified platform for innovation and long-term value. We look forward to continuing to support our customers and partners in the biopharma and foof and beverage sectors with cutting-edge enzyme solutions and the same unwavering commitment, with the added strength and scale of Kerry. Together we look forward to shaping the future of food, beverage, and biopharma innovation. Thank you for your continued trust as we move along this journey.